Declaration of Interest
CTU Bern, including CTU Bern staff, aims at being independent of financially driven biases. CTU Bern acknowledges that clinical research is costly and some research would not be possible without financial support from organizations that have a vested interest (non-financial interests are not covered herein) in the results of the research they support. Therefore, CTU Bern aims at transparency and minimizing financial biases.
CTU Bern has a funding policy that is binding to all staff.
Funding of clinical studies
CTU Bern may be involved in studies that are funded by for-profit organizations with a commercial interest in healthcare. However, CTU Bern ensures transparent reporting of funding sources and endorses access to all study data by academic researchers and unbiased and unrestricted publication of study results. CTU Bern is and will not be involved in any clinical study (co-)funded by the tobacco industry.
List of funding sources
Only major projects listed
CTU Project No. | Name | Funding |
---|---|---|
1798 | Burden of Sleep wake disorders | European Academy of Neurology (EAN) |
1793 | EMBARC | CSL Behring AG |
1779 | TOGETHER | Universitätsklinik für Kardiologie, Inselspital Bern |
1765 | TITAN-DEB | n/a |
1755 | TreoMel | University Hospital/Inselspital |
1746 | SMASH | n/a |
1733 | DMT-HAR-TOM | Reconnect Labs AG |
1729 | INTOMOB | SNF |
1716 | SONOBIRDIE Trial | n/a |
1715 | Single Shot Champion | Research Funds of the Department of Cardiology, Inselspital Bern and University Hospital Basel |
1714 | BELEAVE | Department of Cardiology, Inselspital Bern |
1708 | Cannabispilotversuch Biel | Ad5 GmbH |
1694 | BEready | |
1693 | Umbrella Registry: Zirconia Dental Implants | Z-Systems AG |
1686 | FENDER | SNF |
1685 | DeIntensiFpilot | Swiss Cancer Research |
1672 | COVID-19 Lung Cohort Study | Lungenliga Bern |
1668 | A34RCT | Schweizerische Akademie der Medizinischen Wissenschaften, Swiss Orthopaedics, Ortho Team Bern, SUVA |
1666 | SCRIPT-2 | |
1656 | StOP-2 | SNF |
1655 | HypoFocal-SRT | Debiopharm AG |
1652 | Thalamic Burst-DBS for neuropathic pain | |
1651 | SURPRISE | SNF, Federal Office of Public Health, Health Department of the Kanton St. Gallen |
1645 | TECNO | SNF |
1640 | PREHABIL Trial | SNF, Department of Anaesthesiology and Pain Medicine on the University Hospital Inselspital Bern |
1638 | GAIN-INST-Trial | Spitalzentrum Biel |
1556 | MINOCA | Bangerter-Rhyner Stiftung (Basel, Switzerland) |
1608 | StibTax | n/a |
1601 | LUSPLUS | n/a |
1594 | KIC-START | Pfizer |
1585 | RetroperitonealSarcoma | Universitätsklinik für Medizinische Onkologie Bern |
1575 | SOS Peritonitis | Medical Systems Solution GmbH |
1571 | Paracetamol for cancer pain control | SNF |
1570 | Magrolimab | SNF |
1567 | Co-STAR | Universitätsklinik für Kardiologie, Inselspital Bern |
1564 | HeMoVal | CSL Behring AG |
1561 | Bazedoxifene | HFR Grant |
1548 | MDR-Ent | SNF |
1547 | NEON | InnoMedica Switzerland AG |
1541 | SilexanNMA | n/a |
1532 | Goal-directed mobilization | SGAIM Foundation, Bern, Switzerland |
1513 | RadiotracerPC | Berger-Janser Stiftung zur Krebserforschung & bernische Krebsliga |
1511 | STREAM-75 | SNF |
1495 | DIFU | SNF |
1488 | RET | Johanna Bol Foundation, Baxter Company |
1487 | Tuberculini | Innosuisse |
1474 | SEPAIS | Insel Gruppe AG, Universitätsklinik für Neurologie |
1473 | PASTA Trial | SNF |
1442 | POLICOV | Police Department Canton Bern, Ifik Bern, Interregionale Blutspende SRK Bern |
1423 | COMPARE CRYO | Department of Cardiology Inselspital Bern and University Hospital Basel |
1421 | Solidarity Vaccine Trial | World Health Organization |
1419 | COVID-19 in acute cardio | Insel Gruppe AG, Universitätsklinik für Kardiologie |
1418 | SEECS | SNF |
1417 | PRAETOR-ML | Universitätsklinik für Thoraxchirurgie |
1416 | SWEETSTONE | Boehringer Ingelheim, Basel, Switzerland |
1403 | ROSE | Hans Goldmann Stiftung |
1402 | Swiss Health Study | FOPH, Unisanté and in kind contribution of the Swiss Biobanking Platform (SBP) |
1400 | MPN-Gas6 | SNF (Swiss National Foundation) |
1395 | Ebola Safety Reporting | World Health Organization (WHO) |
1394 | Thrombophilie HZLA Register | University Hospital Bern (Inselspital) |
1366 | SOLIDARITY TRIAL | World Health Organization (WHO) |
1360 | SAM | SNF |
1338 | PHARAO | Departmental Anaesthesia Research Fund |
1335 | Fibrotic NAFLD in diabetes | Gilead |
1315 | AB-PSP-001 | ABIONIC SA |
1310 | SARSCoV-2 and liver transplant | n/a |
1309 | CORON-ACT | University Hospital Bern (Inselspital) and Roche Pharma (Schweiz) AG |
1297 | NIBED | Innosuisse Grant |
1287 | Laser treatment in vulvar Lichen sclerosus | University Hospital Bern (Inselspital) |
1276 | HEADWIND II | SNF |
1275 | HNO support | SynDermix AG |
1253 | VTE RAM Immobilization | Gottfried und Julia Bangerter-Rhyner Stiftung, Novartis Foundation for medical-biological Research |
1243 | Tissue graft versus collagen matrix in the treatment of gingival recessions | Universität Bern Zahnmedizinische Kliniken |
1222 | Nicotine PKPD | Universitätsklinik für Allgemeine Innere Medizin |
1218 | ACT for Insomnia | Velux Stiftung |
1216 | RCT smoking cessation nicotine salt high low concentration | SNF |
1206 | S Napoli | BAG |
1198 | TERIS | CHU de Nice |
1195 | ESG | Scherbarth Stiftung |
1123 | VitCTrial | Campus SLB Sonnenhof AG |
1109 | SAFE SSPE | SNF |
1107 | DapaStudy | SNF |
1106 | SM-FES | Innosuisse Intento SA |
1096 | VANCO | Gottfried and Julia Bangerter & Rhyner Stiftung |
1095 | Ebola Meuri | World Health Organization (WHO) |
1083 | HDMM | Novartis |
1073 | PedIndex | Stiftung Batzebär |
1061 | EpiOs | Wyss Center |
1059 | HemMa SCD | CSL Behring AG |
1058 | SRT Phase I | Universitätsklinik für Augenheilkunde, Inselspital Bern |
1052 | Proaktiv | SNF |
917 | B&B VTablation | Department of Cardiology at University Hospital Bern |
909 | PSP Diagnosis of Sepsis | Abionic |
906 | PAPA ARTiS | German Research Foundation, European Union´s Horizon 2020 |
895 | VoiceS | External grants of Universitätsklinik für Radio-Onkologie, Inselspital Bern |
883 | Bone Anchored Port | Diavantis AG |
881 | GCA Registry | |
877 | PPVRP | Department of Pediatric Surgery, Inselspital University Hospital |
866 | OPTICO LM | Abbott, Heartflow |
856 | EMISI Trial | SNF |
851 | Gynocular Studies | Swiss Cancer Research, National Institute of Allergy and Infectious Diseases of the National Institutes of Health, ESTHER Switzerland foundation |
829 | CONNECT | Boston Scientific |
777 | CARDSUP | University Hospital of Berne |
762 | EUNN | Universitätsklinik für Neurologie, Inselspital Bern, European Narcolepsy Network (EU-NN) |
746 | ESTxENDS | SNF Lungen Liga Bern Swiss Cancer League Tobacco Prevention Fund TPF |
741 | BISS | SNF |
706 | Target READ | SNF |
701 | SWIFTdirect | Medtronic Minneapolis, Minnesota, USA |
690 | Preference Sensitive Care | SNF |
689 | H-PACS | Lifecell |
679 | ELAN | SNF |
677 | Simpl'HIV trial | SNF |
670 | DAWN2 CH | Novo Nordisk AG |
645 | EVOPACS | Amgen Switzerland AG |
640 | NOSTONE | SNF |
639 | TAVI LAAC AFIB | Boston Scientifics |
636 | SERVE | SNF |
634 | MASTER DAPT | Terumo Medical Corporation |
632 | SYMPTOM NAVI Pilot | Stiftung Lindenhof Bern |
613 | SCRIPT | University of Bern |
628 | SCOPE I | Symetis SA |
606 | REVEAL in TAVI | SNF Medtronic (Schweiz) AG |
536 | SAAL | Miltenyi Biotec GmbH |
533 | OPTICO BVS | St. Jude Medical |
524 | Effect of anaesthetic techniques on clinical outcome after LSP, RA vs GA, a prospective RCT | |
468 | OSCAR GALILEO | Bayer AG |
465 | Ebola vaccine trial | WHO |
458 | BIOSTEMI | Biotronik AG |
453 | TOLERANT | Bayer (Schweiz) AG |
449 | DECO-SSI | The Lindenhof Fund for Teaching and Research, Bern |
441 | MDS Registry | Novartis Pharma Schweiz AGCelgene GmbH |
437 | Hämophilie-Register | Swiss Hemophilia Network (SHN)Universitäts-Kinderspital Zürich -Eleonorenstiftung |
430 | PACMAN | Sanofi / Regeneron |
428 | BEB | EMPIRIS Mundipharma Medical Company |
415 | OPERAM | EU HORIZON2020 |
337 | MATRIX | Medicines Company Terumo |
333 | SWITCH | SNF Schweizerische Herzstiftung Inselspital |
228 | SENStrial | SNF |
182 | BAG_HFV-Pilot | |
158 | CLEVER-ACS | SNF |
154 | SAG TCCS | Swisscancer Anna Lisa Stiftung Ostschweizer Stiftung für Klinische Krebsforschung OSKK |
104 | GCA Tocilizumab Rheumatology | Roche Pharma (Switzerland) Ltd |
94 | Bioscience Orsiro | BIOTRONIK |
93 | Bioflow II | BIOTRONIK |
87 | PC Trial | Abbott Cordis Medtronic |
79 | Global LEADERS | Biosensors (Morges, Switzerland), AstraZeneca |
78 | SPIRIT (10.10.CLI) | Nestlé Healthscience |
77 | ETRELKA | ARCO Foundation |
74 | Swiss TAVI Registry | Edwards Medtronic |
52 | HWI | Swiss National Foundation Swiss Academy of Medical Sciences SwissLife foundation Else Kroener-Fresenius foundation |
33 | Lichen | SNF |
31 | TTP Register | SNF Mach-Gaensslen Foundation Baxter Innovations GmbH |
29 | COMFORTABLE-AMI | SNF Biosensors |
28 | SWITCO65+ | SNF |
22 | Titan-Endeavor RCT | Insel Foundation |
19 | LEADERS | Biosensors Europe SA |
16 | HVI_Tanzania | |
7 | TFA | Agroscope |
6 | POC_OP |